16th International Surgical Pathology Symposium

May 5-8, 2009
Radisson SAS Hotel
Berlin, Germany

Course Directors

Gary L. Keeney, MD
Chair, Division of Anatomic Pathology
Department of Laboratory Medicine and Pathology
Associate Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic
Rochester, Minnesota

Thomas C. Smyrk, MD
Consultant, Division of Anatomic Pathology
Department of Laboratory Medicine and Pathology
Associate Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic
Rochester, Minnesota

Guest Faculty

Dr. med. Dr. h.c. Harald Stein
University Professor for Pathology
Director of the Institute for Pathology, Campus Benjamin Franklin
Charité University Medicine Berlin
Berlin, Germany

Mayo Clinic Faculty

Ahmet Dogan, MD, PhD
Consultant, Division of Anatomic Pathology
Department of Laboratory Medicine and Pathology
Professor of Pathology
College of Medicine, Mayo Clinic
Rochester, Minnesota

Lori A. Erickson, MD
Consultant, Division of Anatomic Pathology
Department of Laboratory Medicine and Pathology
Associate Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic
Rochester, Minnesota

Carol Reynolds, MD
Consultant, Division of Anatomic Pathology
Department of Laboratory Medicine and Pathology
Associate Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic
Rochester, Minnesota

Schuyler O. Sanderson, MD
Consultant, Division of Anatomic Pathology
Department of Laboratory Medicine and Pathology
Assistant Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic
Rochester, Minnesota

Bernd Scheithauer, MD
Consultant, Division of Anatomic Pathology
Department of Laboratory Medicine and Pathology
Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic
Rochester, Minnesota

Faculty Disclosure

As a provider accredited by ACCME, College of Medicine, Mayo Clinic must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Thus, safeguards against commercial bias have been put in place. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so that participants in the activity may formulate their own judgments regarding the presentation.